SFGP
RMD icon

Stonebridge Financial Group (Pennsylvania)’s ResMed RMD Stock Holding History

Stonebridge Financial Group (Pennsylvania)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$224 – 788
2025
Q1 		$224 Buy
+1
New +$233 ﹤0.01% 922

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Stonebridge Financial Group (Pennsylvania)'s RMD Position: Q2 2025 in Review

Stonebridge Financial Group (Pennsylvania) sold out of ResMed (RMD) in Q2 2025, closing a stake of 1 share — an estimated $224 sold.

Stonebridge Financial Group (Pennsylvania) first reported a position in RMD in Q1 2025 and held it in 1 quarter. The position peaked at $224 in Q1 2025. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Stonebridge Financial Group (Pennsylvania) reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Stonebridge Financial Group (Pennsylvania) sold 1 ResMed share in Q2 2025, an estimated $224.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in ResMed in Q1 2025 and held it in 1 quarter.
  • Stonebridge Financial Group (Pennsylvania)'s ResMed position peaked at $224 in Q1 2025.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2025, filed 24 Jul 2025.